Glycopeptides and Other Agents Used to Treat Gram-Positive Cocci
Glycopeptide antibiotics are a class of agents, composed of glycosylated cyclic or polycyclic peptides. Clinically useful glycopeptides include vancomycin, teicoplanin, dalavancin, and telavancin.
KeywordsClostridium Difficile Streptococcus Agalactiae Skin Structure Infection Glycopeptide Antibiotic Oral Vancomycin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- Arias, C. A., Contreras, G. A., & Murray, B. E. (2010). Management of Multi-Drug Resistant Enterococcal Infections. Clin Microbiol Infect.Google Scholar
- Dificid® oral tablets [package insert]. San Diego, CA: Optimer Pharmaceuticals Inc, April, 2011.Google Scholar
- Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., et al. (2011). Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis, 52(3), 285–292.PubMedCrossRefGoogle Scholar
- Nailor, M. D., & Sobel, J. D. (2009). Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. Infect Dis Clin North Am, 23(4), 965–982, ix.Google Scholar
© Springer Science+Business Media, LLC 2012